Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Anticonvulsant Effects of Topiramate and Lacosamide on Pilocarpine-Induced Status Epilepticus in Rats: A Role of Reactive Oxygen Species and Inflammation.

Tytuł:
Anticonvulsant Effects of Topiramate and Lacosamide on Pilocarpine-Induced Status Epilepticus in Rats: A Role of Reactive Oxygen Species and Inflammation.
Autorzy:
Shishmanova-Doseva M; Department of Pharmacology and Drug Toxicology, Medical University-Plovdiv, 4002 Plovdiv, Bulgaria.
Peychev L; Department of Pharmacology and Drug Toxicology, Medical University-Plovdiv, 4002 Plovdiv, Bulgaria.
Yoanidu L; Department of Bioorganic Chemistry, Medical University-Plovdiv, 4002 Plovdiv, Bulgaria.
Uzunova Y; Department of Bioorganic Chemistry, Medical University-Plovdiv, 4002 Plovdiv, Bulgaria.
Atanasova M; Department of Biology, Medical University of Pleven, 5800 Pleven, Bulgaria.
Georgieva K; Department of Physiology, Medical University-Plovdiv, 4002 Plovdiv, Bulgaria.
Tchekalarova J; Institute of Neurobiology, Bulgarian Academy of Sciences (BAS), 1113 Sofia, Bulgaria.
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Feb 25; Vol. 22 (5). Date of Electronic Publication: 2021 Feb 25.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI, [2000-
MeSH Terms:
Anticonvulsants/*therapeutic use
Inflammation/*pathology
Lacosamide/*therapeutic use
Reactive Oxygen Species/*metabolism
Status Epilepticus/*chemically induced
Status Epilepticus/*drug therapy
Topiramate/*therapeutic use
Animals ; Anticonvulsants/pharmacology ; Biomarkers/metabolism ; Hippocampus/drug effects ; Hippocampus/pathology ; Hippocampus/physiopathology ; Interleukin-1beta/metabolism ; Lacosamide/pharmacology ; Male ; Motor Activity/drug effects ; Oxidative Stress/drug effects ; Pilocarpine ; Rats, Wistar ; Seizures/physiopathology ; Status Epilepticus/physiopathology ; Topiramate/pharmacology ; Tumor Necrosis Factor-alpha/metabolism ; Rats
References:
Seizure. 2011 Apr;20(3):249-56. (PMID: 21216630)
Anal Biochem. 1976 May 7;72:248-54. (PMID: 942051)
Oxid Med Cell Longev. 2012;2012:795259. (PMID: 22848783)
Neuropharmacology. 2015 Sep;96(Pt A):70-82. (PMID: 25445483)
Brain Res. 2010 Feb 8;1313:270-82. (PMID: 20025852)
PLoS One. 2012;7(6):e39302. (PMID: 22768071)
Epilepsia. 2017 Jun;58(6):933-950. (PMID: 28295226)
Epilepsy Behav. 2017 Aug;73:90-94. (PMID: 28623755)
Epilepsia. 2006 Aug;47(8):1253-84. (PMID: 16922870)
Indian J Biochem Biophys. 1984 Apr;21(2):130-2. (PMID: 6490072)
Epilepsia. 2002;43 Suppl 5:30-5. (PMID: 12121291)
Eur Neuropsychopharmacol. 2008 Oct;18(10):760-7. (PMID: 18701263)
Behav Brain Funct. 2012 May 16;8:21. (PMID: 22591917)
Seizure. 2016 May;38:7-10. (PMID: 27039016)
Epilepsia. 2015 Oct;56(10):1515-23. (PMID: 26336950)
Neuroscience. 2015 Feb 26;287:144-56. (PMID: 25541249)
BMC Complement Altern Med. 2017 Jan 9;17(1):31. (PMID: 28068984)
Epilepsy Res. 2016 Oct;126:126-33. (PMID: 27490898)
Neurosci Lett. 2004 Jul 22;365(2):102-5. (PMID: 15245787)
Brain Res Bull. 2019 Apr;147:22-35. (PMID: 30738136)
Epilepsia. 2004 Dec;45(12):1498-505. (PMID: 15571507)
Epilepsia. 2011 Oct;52(10):e148-52. (PMID: 21801171)
Seizure. 2011 Apr;20(3):257-62. (PMID: 21247777)
Epilepsia. 2010 Jul;51 Suppl 3:34-8. (PMID: 20618397)
FEBS J. 2005 Mar;272(6):1307-12. (PMID: 15752349)
Neurochem Int. 2012 Aug;61(3):405-14. (PMID: 22634224)
Saudi Pharm J. 2020 Dec;28(12):1566-1579. (PMID: 33424250)
Epilepsy Res. 2016 Nov;127:352-357. (PMID: 27721162)
Neurosci Bull. 2012 Jun;28(3):301-8. (PMID: 22622830)
Neuroreport. 2018 Nov 7;29(16):1384-1390. (PMID: 30169428)
Oxid Med Cell Longev. 2017;2017:2817252. (PMID: 28270908)
Trends Pharmacol Sci. 2016 Sep;37(9):768-778. (PMID: 27491897)
Am J Pathol. 2003 Mar;162(3):1027-34. (PMID: 12598335)
Indian J Med Res. 2016 Jul;144(1):104-111. (PMID: 27834333)
Biochem Biophys Res Commun. 2008 Aug 8;372(4):816-20. (PMID: 18519030)
Epilepsia. 2013 Mar;54(3):393-404. (PMID: 23293881)
J Basic Clin Physiol Pharmacol. 2017 Jan 1;28(1):31-42. (PMID: 27658141)
eNeuro. 2015 Nov 09;2(5):. (PMID: 26730400)
Electroencephalogr Clin Neurophysiol. 1972 Mar;32(3):281-94. (PMID: 4110397)
Chin Med J (Engl). 2019 Nov 5;132(21):2628-2635. (PMID: 31658159)
Epilepsy Behav. 2019 Dec;101(Pt B):106285. (PMID: 31711869)
Epilepsy Res. 2018 Sep;145:93-101. (PMID: 29935443)
Folia Neuropathol. 2019;57(2):146-160. (PMID: 31556574)
Eur Neurol. 2007;57(2):65-9. (PMID: 17179706)
Seizure. 2012 Apr;21(3):198-201. (PMID: 22244046)
Neurocrit Care. 2018 Dec;29(3):491-495. (PMID: 29949010)
Turk Neurosurg. 2019;29(5):718-723. (PMID: 31124574)
Epilepsy Behav. 2019 Dec;101(Pt B):106275. (PMID: 31171434)
Epilepsy Res. 2009 Sep;86(1):82-8. (PMID: 19520550)
Brain. 2019 Jul 1;142(7):e39. (PMID: 31145451)
Pharmacol Biochem Behav. 2008 Mar;89(1):1-5. (PMID: 18096215)
Epilepsy Res. 2008 Feb;78(2-3):171-7. (PMID: 18164182)
Inflammation. 2019 Oct;42(5):1913-1924. (PMID: 31267274)
Epilepsy Res. 2015 Sep;115:8-16. (PMID: 26220372)
Oxid Med Cell Longev. 2014;2014:293689. (PMID: 25614776)
Neurochem Int. 2011 Aug;59(2):122-37. (PMID: 21672578)
Grant Information:
Grant No. 6/2018 Medical University - Plovdiv, Bulgaria
Contributed Indexing:
Keywords: IL-1β; TNF-α; anticonvulsants; hippocampus; oxidative stress; status epilepticus
Substance Nomenclature:
0 (Anticonvulsants)
0 (Biomarkers)
0 (Interleukin-1beta)
0 (Reactive Oxygen Species)
0 (Tumor Necrosis Factor-alpha)
01MI4Q9DI3 (Pilocarpine)
0H73WJJ391 (Topiramate)
563KS2PQY5 (Lacosamide)
Entry Date(s):
Date Created: 20210306 Date Completed: 20210416 Latest Revision: 20240226
Update Code:
20240226
PubMed Central ID:
PMC7956388
DOI:
10.3390/ijms22052264
PMID:
33668718
Czasopismo naukowe
Background: Status epilepticus (SE) is a neurological disorder characterized by a prolonged epileptic activity followed by subsequent epileptogenic processes. The aim of the present study was to evaluate the early effects of topiramate (TPM) and lacosamide (LCM) treatment on oxidative stress and inflammatory damage in a model of pilocarpine-induced SE.
Methods: Male Wistar rats were randomly divided into six groups and the two antiepileptic drugs (AEDs), TPM (40 and 80 mg/kg, i.p.) and LCM (10 and 30 mg/kg, i.p.), were injected three times repeatedly after pilocarpine administration. Rats were sacrificed 24 h post-SE and several parameters of oxidative stress and inflammatory response have been explored in the hippocampus.
Results: The two drugs TPM and LCM, in both doses used, succeeded in attenuating the number of motor seizures compared to the SE-veh group 30 min after administration. Pilocarpine-induced SE decreased the superoxide dismutase (SOD) activity and reduced glutathione (GSH) levels while increasing the catalase (CAT) activity, malondialdehyde (MDA), and IL-1β levels compared to the control group. Groups with SE did not affect the TNF-α levels. The treatment with a higher dose of 30 mg/kg LCM restored to control level the SOD activity in the SE group. The two AEDs, in both doses applied, also normalized the CAT activity and MDA levels to control values. In conclusion, we suggest that the antioxidant effect of TPM and LCM might contribute to their anticonvulsant effect against pilocarpine-induced SE, whereas their weak anti-inflammatory effect in the hippocampus is a consequence of reduced SE severity.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies